Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1978-10-25
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Aug
|
| pubmed:issn |
0022-2143
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
92
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
141-3
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:681806-Anemia, Sideroblastic,
pubmed-meshheading:681806-Animals,
pubmed-meshheading:681806-Ascorbic Acid,
pubmed-meshheading:681806-Chelating Agents,
pubmed-meshheading:681806-Deferoxamine,
pubmed-meshheading:681806-Hemosiderosis,
pubmed-meshheading:681806-Humans,
pubmed-meshheading:681806-Iron,
pubmed-meshheading:681806-Metabolic Diseases,
pubmed-meshheading:681806-Thalassemia
|
| pubmed:year |
1978
|
| pubmed:articleTitle |
Chronic iron overload: new chelators and new strategies.
|
| pubmed:publicationType |
Editorial
|